欧扎克银行 OZK 深 沪
等待开盘 10-01 09:30:00 美东时间
45.96
-0.240
-0.52%
华盛通- 最 高46.65
- 今 开46.20
- 成交量 117.15万股
- 最 低 45.75
- 昨 收 46.20
- 总市值 50.12亿
- 52周最高 53.18
- 市盈率 静 7.44
- 换手率 1.07%
- 52周最低 40.96
- 委 比 96.38%
- 总股本 1.09亿
- 历史最高 52.91
- 量 比 0.93
- 振 幅 1.95%
- 历史最低 4.84
- 每 手 1
- 风险率 2.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅919.61%！HC Wainwright上调NeuroSense Therapeutics目标价至52美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持NeuroSense Therapeutics"买入"评级，目标价从8美元升至52美元；HC Wainwright & Co.：维持艾切托"买入"评级，目标价从27美元升至34美元
09-29 08:33
Morgan Stanley Maintains Underweight on Bank OZK, Raises Price Target to $57
Morgan Stanley analyst Manan Gosalia maintains Bank OZK (NASDAQ:OZK) with a Underweight and raises the price target from $56 to $57.
09-28 20:34
美股大行评级 | 多家大行齐上调Robinhood目标价！最高看至150美元；安进股价大跌后评级遭下调
今日重点评级关注：Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.3美元升至8.45美元；摩根大通：维持Vera Therapeutics"超配"评级，目标价从76美元升至83美元
09-09 15:36
Morgan Stanley Downgrades Bank OZK to Underweight, Maintains Price Target to $56
Morgan Stanley analyst Manan Gosalia downgrades Bank OZK (NASDAQ:OZK) from Equal-Weight to Underweight and maintains the price target from $56 to $56.
09-09 01:56
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Wells Fargo Maintains Equal-Weight on Bank OZK, Raises Price Target to $56
Wells Fargo analyst Terry McEvoy maintains Bank OZK (NASDAQ:OZK) with a Equal-Weight and raises the price target from $52 to $56.
08-11 01:23
3 Stocks That Prove You Can Have Both Growth and Income
Wall Street has always insisted that investors must choose sides. You can own growth stocks, which supposedly offer exciting capital gains but little current income. You can own dividend stocks, which provide income but are often dismissed as slow, boring businesses unlikely to produce spectacular l...
08-08 04:30
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
美股大行评级 | 最高120美元！大小摩等7家大行集体上调英特尔目标价；汇丰首予SpaceX"持有"评级，目标价115美元
今日重点评级关注：HC Wainwright & Co.：维持居里"买入"评级，目标价从17美元升至43美元；花旗：维持Klaviyo"买入"评级，目标价从31美元升至34美元
07-27 14:02
TD Cowen Maintains Hold on Bank OZK, Lowers Price Target to $52
TD Cowen analyst Janet Lee maintains Bank OZK (NASDAQ:OZK) with a Hold and lowers the price target from $53 to $52.
07-25 00:46
